Four years after its approval in the United States, transcatheter aortic valve replacement (TAVR) continues to evolve and demonstrate positive outcomes for patients with aortic stenosis, a common heart problem, according to a new report.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1Q9CL0S
No comments:
Post a Comment